- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.03. | Alpha Tau Medical Ltd.: Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit | 1 | GlobeNewswire (USA) | ||
| 25.03. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.03. | Alpha Tau Medical GAAP EPS of -$0.42 | 1 | Seeking Alpha | ||
| 07.03. | Alpha Tau Medical Ltd. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 07.03. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.03. | Alpha Tau Medical Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 07.03. | Alpha Tau Medical Ltd.: Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update | 73 | GlobeNewswire (Europe) | - Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response findings - - ReSTART U.S. multi-center pivotal trial currently... ► Artikel lesen | |
| 26.02. | Alpha Tau Medical Ltd.: Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 26.02. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.12.23 | Alpha Tau Medical Ltd.: Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 20.12.23 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.11.23 | Alpha Tau Medical Ltd.: Alpha Tau to Participate in Sidoti Small-Cap Conference | 1 | GlobeNewswire (USA) | ||
| 28.11.23 | Alpha Tau Medical Ltd.: Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer | 150 | GlobeNewswire (Europe) | - Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received... ► Artikel lesen | |
| 28.11.23 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.11.23 | Alpha Tau Medical Ltd.: Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer | 234 | GlobeNewswire (Europe) | JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, and HekaBio K.K.... ► Artikel lesen | |
| 17.11.23 | Analyst Ratings for Alpha Tau Medical | 1 | Benzinga.com | ||
| 16.11.23 | Alpha Tau Medical GAAP EPS of $0.31 | 1 | Seeking Alpha | ||
| 16.11.23 | Alpha Tau Medical Ltd.: Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update | 301 | GlobeNewswire (Europe) | - Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside safety and feasibility trial in similar indication currently underway... ► Artikel lesen | |
| 16.11.23 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.10.23 | Alpha Tau enters into long-term lease of site in New Hampshire for second U.S. manufacturing facility | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 12,142 | -1,73 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| NANO-X IMAGING | 8,950 | -1,32 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| BUTTERFLY NETWORK | 0,822 | 0,00 % | Butterfly Network expands maternal ultrasound efforts across Africa | ||
| GOODRX | 6,690 | -0,74 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 11,860 | -0,46 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
| CARMAT | 3,830 | +1,06 % | CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024 | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| HYPERFINE | 0,820 | +1,23 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 32,520 | +2,01 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
| BIOMERICA | 0,750 | -0,09 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| MIMEDX | 6,140 | -0,32 % | MiMedx Group, Inc: MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30 | ||
| ATRION | 362,00 | -2,69 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| ATRICURE | 23,300 | -0,38 % | AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management | ||
| AMWELL | 0,521 | 0,00 % | Amwell® to Report First Quarter 2024 Operating Results May 1 | ||
| OUTSET MEDICAL | 2,220 | -0,89 % | Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis | ||
| TALKSPACE | 2,950 | -0,51 % | Talkspace to Report First Quarter 2024 and Host Conference Call |
ALPHA TAU MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +0,75 % bei einem Aktienkurs von 2,680 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
